Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. T. Carpenter, H. Roché, M. Campone, R. Colomer, A. Jagiello-Gruszfeld, L. Moore, M. D’Amore, S. Kong, J. Boni, J. Baselga
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: temsirolimus, letrozole, mTOR inhibitors, metastatic breast cancer, locally advanced breast cancer, postmenopausal women, combination therapy, intermittent dosing, drug toxicity, hyperglycemia, objective response rate, treatment safety, endocrine therapy, PI3K/AKT/mTOR pathway, PI3K inhibitors, HER2-negative breast cancer, hormone receptor-positive breast cancer
Open Access status: closed
OpenAlex ID: W2243880667
